The global cell and tissue preservation market size is calculated at USD 5.20 billion in 2025 and is forecasted to reach around USD 13 billion by 2034, accelerating at a CAGR of 8.31% from 2025 to 2034. The North America cell and tissue preservation market size surpassed USD 1.92 billion in 2024 and is expanding at a CAGR of 10.75% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cell and Tissue Preservation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cell and Tissue Preservation Market, by Type
8.1.1. Cell
8.1.1.1. Market Revenue and Forecast
8.1.2. Tissue
8.1.2.1. Market Revenue and Forecast
9.1. Cell and Tissue Preservation Market, by Application Type
9.1.1. Therapeutics
9.1.1.1. Market Revenue and Forecast
9.1.2. Drug Discovery
9.1.2.1. Market Revenue and Forecast
9.1.3. Gene therapy
9.1.3.1. Market Revenue and Forecast
9.1.4. IVF treatment
9.1.4.1. Market Revenue and Forecast
9.1.5. Research & Development
9.1.5.1. Market Revenue and Forecast
9.1.6. Cell therapy
9.1.6.1. Market Revenue and Forecast
10.1. Cell and Tissue Preservation Market, by Product Type
10.1.1. Equipment
10.1.1.1. Market Revenue and Forecast
10.1.2. Software
10.1.2.1. Market Revenue and Forecast
10.1.3. Bio-preservation Media
10.1.3.1. Market Revenue and Forecast
11.1. Cell and Tissue Preservation Market, by End User Type
11.1.1. Biobanks
11.1.1.1. Market Revenue and Forecast
11.1.2. Hospitals
11.1.2.1. Market Revenue and Forecast
12.1. Cell and Tissue Preservation Market, by Cell Provider
12.1.1. CD34+
12.1.1.1. Market Revenue and Forecast
12.1.2. CD19+
12.1.2.1. Market Revenue and Forecast
12.1.3. MSC
12.1.3.1. Market Revenue and Forecast
12.1.4. iPSC
12.1.4.1. Market Revenue and Forecast
12.1.5. hESC
12.1.5.1. Market Revenue and Forecast
12.1.6. Tumor Cells
12.1.6.1. Market Revenue and Forecast
12.1.7. Others
12.1.7.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type
13.1.2. Market Revenue and Forecast, by Application
13.1.3. Market Revenue and Forecast, by Product
13.1.4. Market Revenue and Forecast, by End User
13.1.5. Market Revenue and Forecast, by Cell Provider
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type
13.1.6.2. Market Revenue and Forecast, by Application
13.1.6.3. Market Revenue and Forecast, by Product
13.1.6.4. Market Revenue and Forecast, by End User
13.1.7. Market Revenue and Forecast, by Cell Provider
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Type
13.1.8.2. Market Revenue and Forecast, by Application
13.1.8.3. Market Revenue and Forecast, by Product
13.1.8.4. Market Revenue and Forecast, by End User
13.1.8.5. Market Revenue and Forecast, by Cell Provider
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type
13.2.2. Market Revenue and Forecast, by Application
13.2.3. Market Revenue and Forecast, by Product
13.2.4. Market Revenue and Forecast, by End User
13.2.5. Market Revenue and Forecast, by Cell Provider
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type
13.2.6.2. Market Revenue and Forecast, by Application
13.2.6.3. Market Revenue and Forecast, by Product
13.2.7. Market Revenue and Forecast, by End User
13.2.8. Market Revenue and Forecast, by Cell Provider
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type
13.2.9.2. Market Revenue and Forecast, by Application
13.2.9.3. Market Revenue and Forecast, by Product
13.2.10. Market Revenue and Forecast, by End User
13.2.11. Market Revenue and Forecast, by Cell Provider
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type
13.2.12.2. Market Revenue and Forecast, by Application
13.2.12.3. Market Revenue and Forecast, by Product
13.2.12.4. Market Revenue and Forecast, by End User
13.2.13. Market Revenue and Forecast, by Cell Provider
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type
13.2.14.2. Market Revenue and Forecast, by Application
13.2.14.3. Market Revenue and Forecast, by Product
13.2.14.4. Market Revenue and Forecast, by End User
13.2.15. Market Revenue and Forecast, by Cell Provider
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type
13.3.2. Market Revenue and Forecast, by Application
13.3.3. Market Revenue and Forecast, by Product
13.3.4. Market Revenue and Forecast, by End User
13.3.5. Market Revenue and Forecast, by Cell Provider
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type
13.3.6.2. Market Revenue and Forecast, by Application
13.3.6.3. Market Revenue and Forecast, by Product
13.3.6.4. Market Revenue and Forecast, by End User
13.3.7. Market Revenue and Forecast, by Cell Provider
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type
13.3.8.2. Market Revenue and Forecast, by Application
13.3.8.3. Market Revenue and Forecast, by Product
13.3.8.4. Market Revenue and Forecast, by End User
13.3.9. Market Revenue and Forecast, by Cell Provider
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type
13.3.10.2. Market Revenue and Forecast, by Application
13.3.10.3. Market Revenue and Forecast, by Product
13.3.10.4. Market Revenue and Forecast, by End User
13.3.10.5. Market Revenue and Forecast, by Cell Provider
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type
13.3.11.2. Market Revenue and Forecast, by Application
13.3.11.3. Market Revenue and Forecast, by Product
13.3.11.4. Market Revenue and Forecast, by End User
13.3.11.5. Market Revenue and Forecast, by Cell Provider
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type
13.4.2. Market Revenue and Forecast, by Application
13.4.3. Market Revenue and Forecast, by Product
13.4.4. Market Revenue and Forecast, by End User
13.4.5. Market Revenue and Forecast, by Cell Provider
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type
13.4.6.2. Market Revenue and Forecast, by Application
13.4.6.3. Market Revenue and Forecast, by Product
13.4.6.4. Market Revenue and Forecast, by End User
13.4.7. Market Revenue and Forecast, by Cell Provider
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type
13.4.8.2. Market Revenue and Forecast, by Application
13.4.8.3. Market Revenue and Forecast, by Product
13.4.8.4. Market Revenue and Forecast, by End User
13.4.9. Market Revenue and Forecast, by Cell Provider
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type
13.4.10.2. Market Revenue and Forecast, by Application
13.4.10.3. Market Revenue and Forecast, by Product
13.4.10.4. Market Revenue and Forecast, by End User
13.4.10.5. Market Revenue and Forecast, by Cell Provider
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type
13.4.11.2. Market Revenue and Forecast, by Application
13.4.11.3. Market Revenue and Forecast, by Product
13.4.11.4. Market Revenue and Forecast, by End User
13.4.11.5. Market Revenue and Forecast, by Cell Provider
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type
13.5.2. Market Revenue and Forecast, by Application
13.5.3. Market Revenue and Forecast, by Product
13.5.4. Market Revenue and Forecast, by End User
13.5.5. Market Revenue and Forecast, by Cell Provider
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type
13.5.6.2. Market Revenue and Forecast, by Application
13.5.6.3. Market Revenue and Forecast, by Product
13.5.6.4. Market Revenue and Forecast, by End User
13.5.7. Market Revenue and Forecast, by Cell Provider
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type
13.5.8.2. Market Revenue and Forecast, by Application
13.5.8.3. Market Revenue and Forecast, by Product
13.5.8.4. Market Revenue and Forecast, by End User
13.5.8.5. Market Revenue and Forecast, by Cell Provider
14.1. Thermo Fisher Scientific, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Lonza
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. BD
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. MerckKGaA
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Cytiva
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Agilent Technologies, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Avantor, Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. FUJIFILM Irvine Scientific
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. BioLifeSolutions Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. AMSBIO
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
14.11. Princeton CryoTech
14.11.1. Company Overview
14.11.2. Product Offerings
14.11.3. Financial Performance
14.11.4. Recent Initiatives
14.12. STEMCELL Technologies Inc.
14.12.1. Company Overview
14.12.2. Product Offerings
14.12.3. Financial Performance
14.12.4. Recent Initiatives
14.13. LGC SeraCare
14.13.1. Company Overview
14.13.2. Product Offerings
14.13.3. Financial Performance
14.13.4. Recent Initiatives
14.14. Corning Incorporated
14.14.1. Company Overview
14.14.2. Product Offerings
14.14.3. Financial Performance
14.14.4. Recent Initiatives
14.15. CellGenix GmbH
14.15.1. Company Overview
14.15.2. Product Offerings
14.15.3. Financial Performance
14.15.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample